Optimer Pharmaceuticals Inc

CIK 1142576 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Optimer Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Mar 26, 2015CT ORDER9999999997-15-006892
Feb 17, 2015SC 13G/A0001193805-15-000236
Feb 20, 2014CT ORDER9999999997-14-001111
Nov 4, 201315-12B0001104659-13-080465
Oct 29, 2013EFFECT9999999995-13-003095
Oct 28, 201340001142576-13-000019
Oct 28, 201340001142576-13-000027
Oct 28, 201340001142576-13-000025
Oct 28, 201340001142576-13-000024
Oct 28, 201340001142576-13-000022
Oct 28, 201340001142576-13-000018
Oct 28, 201340001142576-13-000028
Oct 28, 201340001142576-13-000021
Oct 28, 201340001142576-13-000020
Oct 28, 201340001142576-13-000017
Oct 28, 201340001142576-13-000026
Oct 28, 201340001142576-13-000023
Oct 25, 201340001142576-13-000016
Oct 24, 2013S-8 POS0001104659-13-077587
Oct 24, 2013S-8 POS0001104659-13-077583
Oct 24, 2013S-8 POS0001104659-13-077588
Oct 24, 20138-K0001104659-13-077551
Oct 24, 2013S-8 POS0001104659-13-077585
Oct 24, 2013POS AM0001104659-13-077581
Oct 24, 2013S-8 POS0001104659-13-077591